In conclusion, our results indicate that CK-3 blocks the PI3K/AKT/mTOR and MAPK/ERK signaling pathways and exerts an anti-tumor effect on Hep3B and Bel7402 cells. This evidence concerns the gene MAPK1 and neoplasm.